Farmacogenómica como herramienta fundamental para la medicina personalizada: aplicaciones en la práctica clínica
Author
dc.contributor.author
Quiñones Sepúlveda, Luis
Author
dc.contributor.author
Roco Arriagada, Ángela
Author
dc.contributor.author
Cayún Pellizaris, Juan
Author
dc.contributor.author
Escalante, Paula
Author
dc.contributor.author
Miranda Melo, Carla
Author
dc.contributor.author
Varela Figueroa, Nelson
Author
dc.contributor.author
Meneses, Francisca
Author
dc.contributor.author
Gallegos, Bastián
Author
dc.contributor.author
Zaruma Torres, Fausto
Author
dc.contributor.author
Lares Asseff, Ismael
Admission date
dc.date.accessioned
2018-03-29T13:09:01Z
Available date
dc.date.available
2018-03-29T13:09:01Z
Publication date
dc.date.issued
2017
Cita de ítem
dc.identifier.citation
Rev Med Chile 2017; 145: 483-500
es_ES
Identifier
dc.identifier.other
10.4067/S0034-98872017000400009
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/147067
Abstract
dc.description.abstract
Pharmacogenomics is an emergent field aimed at tailoring pharmacological
therapy. Genetic polymorphisms can modify the expression and
function of enzymes and proteins involved in drug metabolism, affecting
absorption, distribution, biotransformation and excretion as well as the
drug-target interaction. Therefore, the presence of allelic variants will
classify people as poor, extensive or rapid/ultra rapid metabolizers, modifying
drug efficacy and safety. In this work, the state of art in relation
to this discipline is presented and the genetic variants of enzymes that are
involved in drug pharmacokinetics or pharmacodynamics are described.
The effects of these variants on the therapeutic response to drugs used in
our country are also discussed.